Cargando…

Correction: MicroRNA-490-3p inhibits migration and chemoresistance of colorectal cancer cells via targeting TNKS2

Detalles Bibliográficos
Autores principales:	Li, Jing, Mo, Rubing, Zheng, Linmei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604450/ https://www.ncbi.nlm.nih.gov/pubmed/37891603 http://dx.doi.org/10.1186/s12957-023-03219-y

Ejemplares similares

MicroRNA-490-3p inhibits migration and chemoresistance of colorectal cancer cells via targeting TNKS2
por: Li, Jing, et al.
Publicado: (2021)

Inhibition of the cell migration, invasion and chemoresistance of colorectal cancer cells through targeting KLF3 by miR-365a-3p
por: Li, Jing, et al.
Publicado: (2021)

Correction to: MicroRNA-138-5p targets the NFIB-Snail1 axis to inhibit colorectal cancer cell migration and chemoresistance
por: Xu, Weifeng, et al.
Publicado: (2020)

MicroRNA-490-3p and −490-5p in carcinogenesis: Separate or the same goal?
por: Li, Yin, et al.
Publicado: (2021)

MicroRNA-490 inhibits tumorigenesis and progression in breast cancer
por: Zhao, Lin, et al.
Publicado: (2016)

Correction to Lancet Psychiatry 2023; 10: 490–98
Publicado: (2023)

Correction: Colorectal Cancer Migration and Invasion Initiated by microRNA-106a
por: Feng, Bo, et al.
Publicado: (2012)

MicroRNA-490-3p inhibits colorectal cancer metastasis by targeting TGFβR1
por: Xu, Xuehu, et al.
Publicado: (2015)

Correction to Lancet Diabetes Endocrinol 2020; 8: 490–500
Publicado: (2023)

Combinatorial Virtual Screening Revealed a Novel Scaffold for TNKS Inhibition to Combat Colorectal Cancer
por: Chang, Chun-Chun, et al.
Publicado: (2022)

Dihydroartemisinin suppresses proliferation, migration, the Wnt/β-catenin pathway and EMT via TNKS in gastric cancer
por: Ma, Yanmei, et al.
Publicado: (2021)

Dihydroartemisinin suppresses proliferation, migration, the Wnt/β-catenin pathway and EMT via TNKS in gastric cancer
por: Ma, Yanmei, et al.
Publicado: (2022)

MicroRNA-490-3p inhibits proliferation and stimulates apoptosis of ESCC cells via MAPK1 downregulation
por: Zabihula, Baerxiaguli, et al.
Publicado: (2019)

Correction to: Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer
por: Henry, C. E., et al.
Publicado: (2022)

MicroRNA-138-5p targets the NFIB-Snail1 axis to inhibit colorectal cancer cell migration and chemoresistance
por: Xu, Weifeng, et al.
Publicado: (2020)

Correction: MicroRNA-130b Suppresses Migration and Invasion of Colorectal Cancer Cells through Downregulation of Integrin β1
Publicado: (2014)

circ5615 functions as a ceRNA to promote colorectal cancer progression by upregulating TNKS
por: Ma, Zhifei, et al.
Publicado: (2020)

Correction: MicroRNA-17-5p regulates EMT by targeting vimentin in colorectal cancer
por: Kim, Tae Won, et al.
Publicado: (2020)

Correction: Perfluorooctane Sulfonate Disturbs Nanog Expression through miR-490-3p in Mouse Embryonic Stem Cells
por: Xu, Bo, et al.
Publicado: (2019)

MicroRNA-490-3p suppresses hepatocellular carcinoma cell proliferation and migration by targeting the aurora kinase A gene (AURKA)
por: Zhang, Hui, et al.
Publicado: (2019)

MicroRNA-490-3p suppresses the proliferation and invasion of hepatocellular carcinoma cells via targeting TMOD3
por: Wang, Honghua, et al.
Publicado: (2020)

microRNA 490-3P enhances the drug-resistance of human ovarian cancer cells
por: Chen, Shuo, et al.
Publicado: (2014)

Correction: MicroRNA-939 inhibits cell proliferation via targeting LRSAM1 in Hirschsprung’s disease
por: Chen, Guanglin, et al.
Publicado: (2018)

Correction: MicroRNA-379 inhibits the proliferation, migration and invasion of human osteosarcoma cells by targeting EIF4G2
Publicado: (2020)

Correction: MicroRNA-613 inhibits cell growth, migration and invasion of papillary thyroid carcinoma by regulating SphK2
por: Qiu, Wangwang, et al.
Publicado: (2022)

Correction: Mechanical Stretch Inhibits MicroRNA499 via p53 to Regulate Calcineurin-A Expression in Rat Cardiomyocytes
por: Chual, Su-Kiat, et al.
Publicado: (2016)

Correction to: HDAC3 deteriorates colorectal cancer progression via microRNA-296-3p/TGIF1/TGFβ axis
por: Li, Jinxiao, et al.
Publicado: (2021)

Correction: Hypoxia Drives Dihydropyrimidine Dehydrogenase Expression in Macrophages and Confers Chemoresistance in Colorectal Cancer
por: Malier, Marie, et al.
Publicado: (2022)

MicroRNA-490-3p regulates cell proliferation and apoptosis in gastric cancer via direct targeting of AKT1
por: Yu, Hong, et al.
Publicado: (2019)

Erratum to: microRNA 490-3P enhances the drug-resistance of human ovarian cancer cells
por: Chen, Shuo, et al.
Publicado: (2015)

The correlation between microRNA490-3p and TGFα in endometrial carcinoma tumorigenesis and progression
por: Sun, Kai-Xuan, et al.
Publicado: (2016)

RNA-Sequencing Based microRNA Expression Signature of Colorectal Cancer: The Impact of Oncogenic Targets Regulated by miR-490-3p
por: Hozaka, Yuto, et al.
Publicado: (2021)

Correction: Nonin-Lecomte et al. Bacterial Type I Toxins: Folding and Membrane Interactions. Toxins 2021, 13, 490
por: Nonin-Lecomte, Sylvie, et al.
Publicado: (2021)

Epithelial-Mesenchymal Transition and MicroRNAs in Colorectal Cancer Chemoresistance to FOLFOX
por: Escalante, Paula I., et al.
Publicado: (2021)

Correction: Upregulation of microRNA-125b by G-CSF promotes metastasis in colorectal cancer
por: Zhang, Xinghua, et al.
Publicado: (2020)

Correction: Human MicroRNA Targets
por: John, Bino, et al.
Publicado: (2005)

Correction: Silence of cancer susceptibility candidate 9 inhibits gastric cancer and reverses chemoresistance
por: Shang, Chao, et al.
Publicado: (2022)

Correction: miR-27a is a master regulator of metabolic reprogramming and chemoresistance in colorectal cancer
por: Barisciano, Giovannina, et al.
Publicado: (2020)

Correction to: Antagonizing miR-455-3p inhibits chemoresistance and aggressiveness in esophageal squamous cell carcinoma
por: Liu, Aibin, et al.
Publicado: (2021)

Correction: Tumor-suppressive microRNA-218 inhibits tumor angiogenesis via targeting the mTOR component RICTOR in prostate cancer
por: Guan, Bing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q1d7qqomj1ioa6num4ndciurrv